Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?
BACKGROUND
Modern radiotherapy techniques enable delivery of high doses to the target volume without escalating dose to organs at risk, offering the possibility of better local control while preserving good quality of life. Uncertainties in target volume delineation have been demonstrated for most tumour sites, and various studies indicate that inconsistencies in target volume delineation may be larger than errors in all other steps of the treatment planning and delivery process. The aim of this paper is to summarize the degree of delineation uncertainties for different tumour sites reported in the literature and review the effect of strategies to minimize them.


CONCLUSIONS
Our review confirmed that interobserver variability in target volume contouring represents the largest uncertainty in the process for most tumour sites, potentially resulting in a systematic error in dose delivery, which could influence local control in individual patients. For most tumour sites the optimal combination of imaging modalities for target delineation still needs to be determined. Strict use of delineation guidelines and protocols is advisable both in every day clinical practice and in clinical studies to diminish interobserver variability. Continuing medical education of radiation oncologists cannot be overemphasized, intensive formal training on interpretation of sectional imaging should be included in the program for radiation oncology residents.
Department of Radiation Oncology, Institute of Oncology Ljubljana, Slovenia.
Barbara
B
Segedin
Department of Radation Oncology, National Centre for Cancer Care and Research, Doha, Qatar.
Primoz
P
Petric
delineation uncertainties; imaging; interobserver variability; target volume; training
Jacobs J Radiat Oncol. 2014 Sep;1(1):006
25568889
Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):428-34
18037584
Strahlenther Onkol. 2011 Jun;187(6):357-66
21603989
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):435-48
16198064
Acta Oncol. 2013 May;52(4):703-10
23421926
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92 (4):911-20
26104943
Semin Radiat Oncol. 2005 Jul;15(3):136-45
15983939
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):763-70
17379435
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1269-79
14630261
Radiother Oncol. 2003 Apr;67(1):87-95
12758244
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):481-9
20400244
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1037-42
22878126
Radiother Oncol. 2005 May;75(2):217-23
15885831
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):136-41
18538492
Radiother Oncol. 2010 Mar;94(3):286-91
20199818
Brachytherapy. 2015 Nov-Dec;14 (6):925-32
26209477
Radiother Oncol. 2012 Jan;102(1):14-21
21903287
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):804-11
20843611
Cancer Radiother. 2014 Mar;18(2):89-96
24440683
J Med Imaging Radiat Oncol. 2016 Apr;60(2):255-9
26568515
Radiat Oncol. 2011 Sep 19;6:118
21929770
Strahlenther Onkol. 2005 Jul;181(7):424-30
15995835
Radiother Oncol. 2000 Jul;56(1):73-83
10869758
Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):481-8
12957260
Strahlenther Onkol. 2003 Jan;179(1):21-30
12540981
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):348-55
20472347
Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1366-72
11483349
Radiat Oncol. 2010 Mar 15;5:21
20230613
Radiology. 2004 Oct;233(1):93-100
15317953
Radiother Oncol. 2012 May;103(2):178-82
22265730
Radiother Oncol. 2013 Apr;107(1):1-5
23541642
Ann Nucl Med. 2007 Dec;21(10 ):553-62
18092131
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):57-66
9989514
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92 (4):874-83
26104940
Technol Cancer Res Treat. 2010 Aug;9(4):393-8
20626204
Br J Radiol. 2013 Apr;86(1024):20120398
23392188
Strahlenther Onkol. 2015 Jun;191(6):525-33
25665799
Radiother Oncol. 2013 Apr;107(1):13-9
23462706
Radiother Oncol. 2005 Nov;77(2):182-90
16256231
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):435-41.e1
21075551
Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):372-6
16965989
Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):277-88
9788405
Radiother Oncol. 2005 Oct;77(1):25-31
15919126
Radiother Oncol. 2014 Jan;110(1):172-81
24183870
Radiother Oncol. 2001 Jul;60(1):49-59
11410304
Radiother Oncol. 2013 Apr;107(1):6-12
23453539
Radiother Oncol. 2002 Jan;62(1):37-49
11830311
Radiat Oncol. 2008 Dec 09;3:41
19068126
Radiother Oncol. 1993 Nov;29(2):169-75
8310142
Med Phys. 2013 Apr;40(4):040601
23556869
Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):566-73
12062598
Clin Oncol (R Coll Radiol). 2009 Apr;21(3):204-17
19250811
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e265-72
21620581
Radiother Oncol. 2005 Mar;74(3):235-45
15763303
Radiother Oncol. 2012 Apr;103(1):92-8
22405806
Radiother Oncol. 2005 Sep;76(3):293-9
16165237
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1923-9
21514071
Radiother Oncol. 2012 Mar;102(3):371-6
22280807
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1332-40
21708426
Strahlenther Onkol. 2012 Feb;188(2):160-7
22281878
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1166-70
19836158
Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):457-61
12243822
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):990-3
19345515
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):70-5
15850904
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):379-85
19467804
Radiol Oncol. 2012 Sep;46(3):242-51
23077463
Radiother Oncol. 2002 Jan;62(1):27-36
11830310
Technol Cancer Res Treat. 2007 Feb;6(1):31-6
17241098
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1233-44
23632957
Radiother Oncol. 1999 Dec;53(3):247-55
10660205
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):220-7
22035663
Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):931-5
10386652
Radiother Oncol. 2011 Jul;100(1):116-23
21821305
Australas Radiol. 1990 Nov;34(4):288-92
2092654
Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):109-12
7995740